The study of serum ferritin level as a predictor of growth retardation in Thalassemia-major

Authors

Abstract

Objective: This work aims to estimate serum ferritin levels of the B-thalassemia major (BTM) patients in one of the Iraqi thalassemia centers and to evaluate its relationship with their retarded growth.

Methods: this was a cross-sectional study that included 163-patients diagnosed with BTM, undergoing continuous red cells transfusion and chelation therapy. The patients' serum ferritin, height, weight, and body mass index (BMI) was measured. The patients were classified into three groups based on their growth states. All the qualitative parameters were displayed as numerical data and percentages, though the quantitative parameters had displayed as mean ± SD. The variations amongst the 3-groups were analyzed by ANOVA test. The regression fit curves between serum ferritin and growth variables were evaluated. The ROC was examined for ferritin value and growth failure. A p<5% was considered as significant.

Results: The mean age of the studied subjects were 12.6±3.5 years (range 3–19 years). The mean serum ferritin levels were 1812 ±1024.9 ng/mL, which showed a significant correlation with height, weight, and age. The mean height Z-score was -2.1±1.1, and 70% of the patients had growth failure (GF). The mean weight Z-score was -2.0 ±1.3. Both height and weight had a significant correlation with ferritin levels in BTM patients. ROC-curves revealed a sensitivity, specificity, and CI% of [72%,78% & (0.703-0.858)], respectively for predictability of serum ferritin for GF in BTM patients.  

Conclusion: In BTM patients, the overall incidence of GF (both mild and severe form) was more than 70%. The mean serum ferritin levels correlated significantly with the growth retardation of BTM patients.

Keywords: growth retardation, β-thalassemia major, ferritin, iron overload.

Downloads

Download data is not yet available.

References

Fouad Shareef Dleikh, A.J.A.-A., Rebee Mohsin, Mazin Jaafar Mousa, Hayder Abdul-Amir, et al. Possible cause-and-effect linkage of transforming growth factor-beta1 and platelets derived growth factor-AB with delayed anthropometric parameters in adolescent patients with Cooley’s anemia: Cases vis control research strategy. EurAsian Journal of BioSciences, 2020. 14: 7.1119-1125.

Mohsin R., B.A., Shakeer W., Makki H., Mazin J., Fouad S., A study of Linear Growth in β-Thalassemia Major Patients: A cross-sectional study from Babylon Hereditary Blood Disorders Center in Babylon. Indian Journal of Forensic Medicine and Toxicology, 2021. 12(2).

Bhavana Singhal, N.S.a. R.M., Iron-overload and Growth of Thalassemic Patients in Marwar Region. International Journal of Pharmaceutical Sciences and Research, 2012. 20(3):6.

Hayder M., Mazin. J., Shaker A., No Significant Relationship of Ferritin Levels to the Levels of Platelet-derived Growth Factor (PDGF) in the Peripheral Blood of Transfusion-dependent ß-Thalassemia Major Patients with Growth Retardation. International Journal of Pharmaceutical Research, 2020. 12(3): 258-65.

Makki H., M.M., Asseel K., Al-Saad R., AL-Dujaili W., Relationship of levels of transforming growth factorbeta1 (TGF-β1) to the levels of ferritin in blood of transfusion dependent β-thalassemia major patients with growth retardation: A case-control study. EurAsian Journal of BioSciences, 2020. 14: 7, 521-527.

de Oliveira GJ, B.S., Cesa CC, Pellanda LC Comparison of NCHS, CDC, and WHO curves in children with cardiovascular risk. . Revista da Associação Médica Brasileira (English Edition) 2013. 59(4): 6.

Rahul Jahagirdar, S.P., Ruma Deshpande, Sanjay Lalwani, Growth profile of children with thalassemia major. Pediatrics, 2017. 7(1).

Abdulwahid, D.A. and M.K. Hassan, β- and α-Thalassemia intermedia in Basra, Southern Iraq. Hemoglobin, 2013. 37(6): 553-63.

Amin, S.S., et al., Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq. BioMed Research International, 2020. 2020: 2807120.

Karamifar, H., et al., Endocrine function in thalassemia intermedia. International Journal Of Biomedical Science: IJBS, 2006. 2(3): 236-240.

De Sanctis, V. Tangerini, A. Testa, M. R. Lauriola, A. L. Gamberini, M. R. Cavallini, A et al., Final height and endocrine function in thalassemia intermedia. J Pediatr Endocrinol Metab, 1998. 11 Suppl 3: 965-71.

Rathaur VK, I.A., Pathania M., Growth pattern in thalassemic children and their correlation with serum ferritin.2020;9:1166-9. J Family Med Prim Care 2020. 9: 4.

Hashemi, A., Ghilian, R., Golestan, M., Akhavan G. Mahvash, Z., Dehghani, M., The Study of Growth in Thalassemic Patients and its Correlation with Serum Ferritin Level %J Iranian Journal of Pediatric Hematology and Oncology. 2011. 1(4): 147-151.

Rodda, C. P., Reid, E. D., Johnson, S., Doery, J., Matthews, R., Bowden, D. K., Short stature in homozygous beta-thalassaemia is due to disproportionate truncal shortening. Clin Endocrinol (Oxf), 1995. 42(6): 16.

Low, C.K., et al., The effect of platyspondyly and pubertal growth spurt on the stature of patients with beta-thalassaemia major. Chin Med J (Engl), 1998. 111(8): 5.

Saxena, A., Growth Retardation in Thalassemia Major Patients. International Journal of Human Genetics, 2003. 3(4): 237-246.

Kyriakou, A. and N. Skordis, Thalassaemia and aberrations of growth and puberty. . Mediterranean journal of hematology and infectious diseases, 2009. 1(1).

Raghdan Z. Al-Saad, A.K., Fouad S., Hayder A.A., Is There Any Association Between Highly Sensitive C-Reactive Protein and Dental-Status in Ischemic Heart Diseases? Comparative-Study Biochemical and Cellular Archives, 2020. 20(2), 6069-6075.

Abbas A., A-A. Hayder, Chabuk S., Mousa M., Conicity index as an Anthropometric Index of Central Obesity in the Prediction of Adult Bronchial Asthma; Correlation with Fractional Exhaled Nitrous Oxide Tests. Medico-Legal Update, 2021. 21(2).

Buonanno G., V.A., Gonnella F., Cantore N, de Bellis G., Serum ferritin in beta‑thalassaemia intermedia. Scand J Haematol 1984. 32: 5.

Karunaratna AMDS, R.J., Mudiyanse RM., Iron-overload in beta thalassemia major patients. Int J Blood Transfus Immunohematol 2017. 7: 8.

Shuvraneel B., T.K.D., Pranab K., Rajib De, Prakas K., Prantar C., Does Thyroid Dysfunction Correlates with Iron-overload in Eβ Thalassemia Patients? A Study from a Tertiary Care Thalassemia Center in India. Arch Med Health Sci 22019. 7: 6.

Bushra M., A.H., Sobiya S., Ahmed R., Bilal H. & Manesh G., Anthropometric measurements in children having transfusion-dependent beta thalassemia. Hematology, 2018. 23(4): 6.

Shalitin, S., Carmi, D., Weintrob, N. Phillip, M. Miskin, H. Kornreich, L., et al., Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol, 2005. 74(2): 93-100.

Downloads

Published

2023-03-30

How to Cite

Bash, H. S. ., Al-Hindy, H. A.-A., Al-Mamory, B. H. ., & Mazin, . J. (2023). The study of serum ferritin level as a predictor of growth retardation in Thalassemia-major. AVFT – Archivos Venezolanos De Farmacología Y Terapéutica, 40(5). Retrieved from http://saber.ucv.ve/ojs/index.php/rev_aavft/article/view/25855